April 21, 2026 — The momentum behind the Homeopathic Drug Product Safety, Quality, and Transparency Act continues to grow. Representative Burgess Owens (R-UT) has become the latest member of Congress to sign on as a co-sponsor of HR 7050, joining a growing bipartisan coalition committed to bringing clarity and consumer protection to the homeopathic drug products market.
About Representative Owens
Representative Burgess Owens represents Utah’s 4th Congressional District and brings a distinctive background to Congress — a former NFL safety turned business executive and advocate for economic opportunity, education reform, and veterans’ support. His decision to co-sponsor HR 7050 adds further Utah representation to the bill, alongside fellow co-sponsor Representative Dr. Mike Kennedy (R-UT), who joined at the bill’s introduction in January.
Growing Support for the Bill
HR 7050 was introduced on January 14, 2026 by sponsor Representative Pete Sessions (R-TX) and has steadily expanded its base of support in the months since. The bill now counts three co-sponsors:
- Representative Jonathan Jackson (D-IL)
- Representative Dr. Mike Kennedy (R-UT)
- Representative Burgess Owens (R-UT) (joined April 21, 2026)
The bill has been referred to the House Committee on Energy and Commerce, where it awaits further action.
Why This Matters
Each new co-sponsor signals expanding congressional recognition that homeopathic products — used by millions of Americans — deserve a clear, dedicated regulatory pathway. Representative Owens’s support reinforces Utah’s strong presence on this issue and underscores that this is not a fringe concern but one with real legislative traction across districts and political backgrounds.
With three co-sponsors now on record and bipartisan backing from the start, HR 7050 continues building the foundation it needs to advance through committee and onto the House floor.
